OpGen, Inc. (OPGN)
 OTCMKTS  · Delayed Price · Currency is USD  
0.0002
 0.00 (0.00%)
  Oct 29, 2025, 4:00 PM EDT
OpGen Revenue
OpGen had revenue of $5.03M in the twelve months ending March 31, 2025, up 88.10% year-over-year. In the year 2024, OpGen had annual revenue of $5.20M with 52.01% growth.
Revenue (ttm) 
 5.03M
Revenue Growth 
 +88.10%
P/S Ratio 
 0.00
Revenue / Employee 
 5.03M
Employees 
 1
Market Cap 
2.01K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 5.20M | 1.78M | 52.01% | 
| Dec 31, 2023 | 3.42M | 811.03K | 31.11% | 
| Dec 31, 2022 | 2.61M | -1.70M | -39.45% | 
| Dec 31, 2021 | 4.31M | 91.59K | 2.17% | 
| Dec 31, 2020 | 4.21M | 715.83K | 20.46% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| American Oncology Network | 1.76B | 
| Veradigm | 588.02M | 
| Jushi Holdings | 256.36M | 
| Glass House Brands | 221.55M | 
| Elite Pharmaceuticals | 105.45M | 
| Silence Therapeutics | 27.17M | 
| Nuo Therapeutics | 1.95M | 
| Northwest Biotherapeutics | 1.09M | 
OpGen News
- 1 year ago - OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q - GlobeNewsWire
- 1 year ago - OpGen Announced 1-for-10 Reverse Stock Split - GlobeNewsWire
- 1 year ago - OpGen Provides Update on Business Operations and Strategic Opportunities - GlobeNewsWire
- 1 year ago - OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K - GlobeNewsWire
- 1 year ago - OpGen Announces Acquisition of Preferred Stock by David Lazar - GlobeNewsWire
- 2 years ago - OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 2 years ago - OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds - GlobeNewsWire
- 2 years ago - OpGen, Inc. (OPGN) Q2 2023 Earnings Call Transcript - Seeking Alpha